Tang, Fengming

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: A multicenter randomized trial

Nassif, M. E., Windsor, S. L., Borlaug, B. A., Kitzman, D. W., Shah, S. J., Tang, F., Khariton, Y., Malik, A. O., Khumri, T., Umpierrez, G., et al. (2021) · Nature Medicine

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 618

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial

Nassif, M. E., Windsor, S. L., Tang, F., Khariton, Y., Husain, M., Inzucchi, S. E., McGuire, D. K., Pitt, B., Scirica, B. M., Austin, B., et al. (2019) · Circulation

Heart Failure Treatment and ManagementDiabetes Treatment and Management

Cited by 424

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): A randomised, double-blind, placebo-controlled, phase 3 trial

Kosiborod, M. N., Esterline, R., Furtado, R. H. M., Oscarsson, J., Gasparyan, S. B., Koch, G. G., Martinez, F., Mukhtar, O., Verma, S., Chopra, V., et al. (2021) · The Lancet Diabetes & Endocrinology

COVID-19 Clinical Research StudiesDiabetes Treatment and Management

Cited by 243

Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project

Arnold, S. V., Inzucchi, S. E., Tang, F., McGuire, D. K., Mehta, S. N., Maddox, T. M., Goyal, A., Sperling, L. S., Einhorn, D., Wong, N. D., et al. (2017) · European Journal of Preventive Cardiology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 144

Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide

Pokharel, Y., Tang, F., Jones, P. G., Nambi, V., Bittner, V. A., Hira, R. S., Nasir, K., Chan, P. S., Maddox, T. M., Oetgen, W. J., et al. (2017) · JAMA Cardiology

Lipoproteins and Cardiovascular HealthClinical practice guidelines implementation

Cited by 107

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER

Arnold, S. V., Tang, F., Cooper, A., Chen, H., Gomes, M. B., Rathmann, W., Shimomura, I., Vora, J., Watada, H., Khunti, K., et al. (2022) · BMC Endocrine Disorders

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 86

Resuscitation Practices Associated With Survival After In-Hospital Cardiac Arrest: A Nationwide Survey

Chan, P. S., Krein, S. L., Tang, F., Iwashyna, T. J., Harrod, M., Kennedy, M., Lehrich, J., Kronick, S., Nallamothu, B. K., & for the American Heart Association’s Get With the Guidelines–Resuscitation Investigators (2016) · JAMA Cardiology

Cardiac Arrest and ResuscitationPalliative Care and End-of-Life Issues

Cited by 76

Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

Grodzinsky, A., Kosiborod, M., Tang, F., Jones, P. G., McGuire, D. K., Spertus, J. A., Beltrame, J. F., Jang, J.-S., Goyal, A., Butala, N. M., et al. (2017) · Circulation: Cardiovascular Quality and Outcomes

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 20